Get more Radiology AI news with our free newsletter.

By signing up you content to our privacy policy

InMed.AI gets FDA nod for NeuroShield

Pune, India-based InMed.AI (InMed Prognostics) has received 510(k) clearance from the U.S. Food and Drug Administration for its NeuroShield technology for use in MRI.

NeuroShield is a fully automated brain geometry- and cloud-based platform designed for neurologists and neuroradiologists. The software takes 3D MR images as inputs and automatically calculates brain volumes that can assist physicians in developing treatment plans for patients with neurodegenerative diseases such as dementia, Alzheimer’s disease, Parkinson’s disease, and epilepsy, InMed said.

In a trial with 280 patients drawn…

Go to publisher site for the complete article:

Read More

Radiology AI
Compare items
  • Total (0)